Clinical Trial Update: Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients [Phase 4]

View source ↗

Summary

Clinical trial update on transitioning to ferric citrate for hyperphosphatemia in dialysis patients (Phase 4) with completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• Ferric citrate (ferric citrate)

Snippet

Sponsor: Kaiser Permanente | Conditions: Hyperphosphatemia | Phase 4 | Status: COMPLETED | Results posted: 2022-01-13